Addus HomeCare Corporation $ADUS is Summit Creek Advisors LLC’s Largest Position

Summit Creek Advisors LLC trimmed its holdings in shares of Addus HomeCare Corporation (NASDAQ:ADUS) by 7.4% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 184,882 shares of the company’s stock after selling 14,788 shares during the quarter. Addus HomeCare makes up approximately 3.2% of Summit Creek Advisors LLC’s investment portfolio, making the stock its largest position. Summit Creek Advisors LLC owned approximately 1.00% of Addus HomeCare worth $21,814,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Royal Bank of Canada increased its holdings in Addus HomeCare by 24.3% in the 1st quarter. Royal Bank of Canada now owns 6,899 shares of the company’s stock worth $682,000 after acquiring an additional 1,347 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in Addus HomeCare by 4.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 10,374 shares of the company’s stock valued at $1,026,000 after purchasing an additional 459 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in Addus HomeCare by 6.1% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 51,679 shares of the company’s stock valued at $5,111,000 after purchasing an additional 2,952 shares in the last quarter. Jane Street Group LLC grew its position in shares of Addus HomeCare by 387.6% in the first quarter. Jane Street Group LLC now owns 11,045 shares of the company’s stock valued at $1,092,000 after purchasing an additional 8,780 shares during the period. Finally, Intech Investment Management LLC increased its stake in shares of Addus HomeCare by 44.7% during the first quarter. Intech Investment Management LLC now owns 14,362 shares of the company’s stock worth $1,420,000 after purchasing an additional 4,439 shares in the last quarter. Hedge funds and other institutional investors own 95.35% of the company’s stock.

Addus HomeCare Trading Down 2.3%

ADUS opened at $109.72 on Monday. The firm has a market capitalization of $2.03 billion, a price-to-earnings ratio of 23.49, a price-to-earnings-growth ratio of 1.32 and a beta of 0.92. The company’s 50 day simple moving average is $113.11 and its two-hundred day simple moving average is $113.42. Addus HomeCare Corporation has a 1-year low of $88.96 and a 1-year high of $136.72. The company has a debt-to-equity ratio of 0.14, a current ratio of 1.66 and a quick ratio of 1.66.

Addus HomeCare (NASDAQ:ADUS) last posted its quarterly earnings results on Monday, November 3rd. The company reported $1.56 EPS for the quarter, beating the consensus estimate of $1.53 by $0.03. Addus HomeCare had a return on equity of 9.53% and a net margin of 6.36%.The firm had revenue of $362.30 million during the quarter, compared to analysts’ expectations of $354.48 million. During the same quarter last year, the firm earned $1.30 earnings per share. The business’s revenue for the quarter was up 25.0% on a year-over-year basis. Analysts expect that Addus HomeCare Corporation will post 4.59 EPS for the current fiscal year.

Insider Activity at Addus HomeCare

In other news, EVP Darby Anderson sold 20,000 shares of Addus HomeCare stock in a transaction on Wednesday, November 19th. The stock was sold at an average price of $109.00, for a total transaction of $2,180,000.00. Following the transaction, the executive vice president owned 44,144 shares in the company, valued at $4,811,696. The trade was a 31.18% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In the last 90 days, insiders sold 20,316 shares of company stock worth $2,215,998. 4.50% of the stock is owned by insiders.

Wall Street Analyst Weigh In

Several research firms recently weighed in on ADUS. Royal Bank Of Canada upped their price target on shares of Addus HomeCare from $134.00 to $139.00 and gave the stock an “outperform” rating in a research report on Friday, November 7th. Barclays boosted their price objective on Addus HomeCare from $111.00 to $117.00 and gave the stock an “underweight” rating in a research note on Tuesday, November 4th. Cowen reissued a “buy” rating on shares of Addus HomeCare in a report on Wednesday, November 5th. TD Cowen lifted their price target on Addus HomeCare from $139.00 to $140.00 and gave the stock a “buy” rating in a research note on Wednesday, November 5th. Finally, Truist Financial set a $135.00 price target on Addus HomeCare and gave the stock a “buy” rating in a research report on Wednesday. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $136.90.

About Addus HomeCare

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.